Anti-Inflammatory and Neuroprotective Effects of Undaria pinnatifida Fucoidan
Marine Drugs · 2025
DOI: 10.3390/md23090350 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, 2025. Verfasst von Cheng Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia. Hauptthemen laut MEDLINE: Polysaccharides, Neuroprotective Agents, Undaria, Anti-Inflammatory Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Marine Bioproducts Cooperative Research Centre (MBCRC).
Abstract (Originalsprache)
Undaria pinnatifida fucoidan (UPF), a sulphated polysaccharide derived from brown seaweed, has attracted scientific and clinical interest for its wide-ranging anti-inflammatory and neurodegenerative properties. A growing body of research shows that UPF inhibits NF-κB and MAPK signalling pathways, reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), decreases ROS production, and suppresses iNOS and COX-2 activity, thereby mitigating oxidative and inflammatory damage in vitro. In vivo studies confirm these actions, demonstrating reduced systemic inflammation, promoted antioxidant defence, modulated gut microbiota composition, and improved production of beneficial microbial metabolites. In parallel, emerging evidence highlights UPF’s neuroprotective potential, characterised by protection against neuroinflammation and oxidative stress, the attenuation of amyloid-beta deposition, and improvement in neuronal function. Importantly, low- to medium-molecular-weight and highly sulphated UPF fractions consistently exhibit stronger bioactivities, suggesting a structural basis for its therapeutic potential. This review integrates mechanistic evidence from cellular, preclinical, and emerging clinical studies, highlighting UPF as a versatile marine-derived agent with therapeutic relevance for inflammatory and neurodegenerative diseases, and outlines future research directions toward clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health, School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia.
- Marinova Pty Ltd., 249 Kennedy Drive, Cambridge, TAS 7170, Australia.
- Central Science Laboratory, College of Science and Engineering, University of Tasmania, Hobart, TAS 7001, Australia.
- School of Psychological Sciences, Psychology, University of Tasmania, Launceston, TAS 7248, Australia.
ORCID-Profile: Cheng Yang, Corinna Dwan, Fionnghuala James, Jigme Thinley, Richard Wilson, Vanni Caruso
Förderung
- The Marine Bioproducts Cooperative Research Centre (MBCRC)
Zitieren
APA
Yang, C., Dwan, C., Wimmer, B. C., Ahamed, S. K., James, F., Thinley, J., Wilson, R., Johnson, L., & Caruso, V. (2025). Anti-Inflammatory and Neuroprotective Effects of Undaria pinnatifida Fucoidan. Marine Drugs. https://doi.org/10.3390/md23090350
Vancouver
Yang C, Dwan C, Wimmer BC, Ahamed SK, James F, Thinley J, et al. Anti-Inflammatory and Neuroprotective Effects of Undaria pinnatifida Fucoidan. Marine Drugs. 2025. doi:10.3390/md23090350
BibTeX
@article{Yang2025,
author = {Yang, Cheng and Dwan, Corinna and Wimmer, Barbara C and Ahamed, Sayed Koushik and James, Fionnghuala and Thinley, Jigme and Wilson, Richard and Johnson, Luke and Caruso, Vanni},
title = {Anti-Inflammatory and Neuroprotective Effects of Undaria pinnatifida Fucoidan},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23090350}
}
EUVIMED